← Back to Search

Dietary Intervention

Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease (PRODUCE Trial)

N/A
Waitlist Available
Led By Heather C Kaplan, MD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, week 4, week 10, week 12 and up to 2 -4 more times as standard of care visits for the duration of the study (34 weeks from randomization)
Awards & highlights
No Placebo-Only Group

Summary

This trial will look at how different diets can help reduce symptoms and inflammation in young patients. The goal is to see if changing their diet can better manage their condition.

Eligible Conditions
  • Ulcerative Colitis
  • Crohn's Disease
  • Inflammatory Bowel Disease
  • Colitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, week 4, week 10, week 12 and up to 2 -4 more times as standard of care visits for the duration of the study (34 weeks from randomization)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, week 4, week 10, week 12 and up to 2 -4 more times as standard of care visits for the duration of the study (34 weeks from randomization) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Fecal Calprotectin
Gastrointestinal Symptoms
Pain Interference
+2 more
Secondary study objectives
Growth
Laboratory markers of disease activity and inflammation
Pediatric Ulcerative Colitis Activity Index (PUCAI)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Specific Carbohydrate Diet (First)Experimental Treatment2 Interventions
Participants will be following the Specific Carbohydrate Diet (SCD). Allowed foods include meat/fish/poultry, eggs, some legumes (e.g., lentils and split peas are permitted, chickpeas and soybeans are not), fully fermented yogurt, non-starchy vegetables, ripe fruit, nuts/seeds, honey and nut flours (e.g. almond flour or coconut flour). Restricted foods include all grains, milk products aside from 24-hour fermented SCD yogurt and cheeses aged greater than 30 days, starchy vegetables, processed foods with food additives and sweeteners other than honey.
Group II: Modified Specific Carbohydrate Diet (First)Experimental Treatment2 Interventions
Participants will be following a modified Specific Carbohydrate Diet (MSCD). In addition to the foods in the SCD, allowed foods will expand to include organic rice, oats, sweet potatoes, grade A maple syrup and cocoa. Gluten, corn products, milk products (except yogurt and hard cheeses), sweeteners (except honey), and process foods are still restricted.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoOTHER
2,591 Previous Clinical Trials
14,901,549 Total Patients Enrolled
Seattle Children's HospitalOTHER
310 Previous Clinical Trials
5,231,176 Total Patients Enrolled
Children's Hospital Medical Center, CincinnatiLead Sponsor
839 Previous Clinical Trials
6,565,563 Total Patients Enrolled
Dayton Children's HospitalOTHER
12 Previous Clinical Trials
5,028,475 Total Patients Enrolled
Brown UniversityOTHER
466 Previous Clinical Trials
698,933 Total Patients Enrolled
Heather C Kaplan, MDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
Lisa Opipari-Arrigan, PhDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
~7 spots leftby Dec 2025